Correlation Between Amicus Therapeutics and Organon

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Organon Co, you can compare the effects of market volatilities on Amicus Therapeutics and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Organon.

Diversification Opportunities for Amicus Therapeutics and Organon

0.64

Correlation Coefficient

Amicus Therapeutics  Organon

Poor diversification

The 3 months correlation between Amicus and Organon is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Organon go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Organon

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Organon. In addition to that, Amicus Therapeutics is 1.34 times more volatile than Organon Co. It trades about -0.1 of its total potential returns per unit of risk. Organon Co is currently generating about 0.08 per unit of volatility. If you would invest  1,505  in Organon Co on October 9, 2024 and sell it today you would earn a total of  43.00  from holding Organon Co or generate 2.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Organon Co

Amicus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Organon

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest sluggish performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Amicus Therapeutics and Organon

The main advantage of trading using opposite Amicus Therapeutics and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.

The idea behind Amicus Therapeutics and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.